Functions of caspase 8: The identified and the mysterious

Seminars in Immunology

Volumn 26, Issue 3, 2014, Pages 246-252

  Salvesen, Guy S ^a   Walsh, Craig M ^b  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Autophagy; Necroptosis; Necrosis

Indexed keywords

CASPASE 10; CASPASE 8; DEATH RECEPTOR; FLICE INHIBITORY PROTEIN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; CELL PROTECTION; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; ENZYME SPECIFICITY; HEMATOPOIETIC CELL; HUMAN; MACROAUTOPHAGY; MOLECULAR EVOLUTION; MOLECULAR INTERACTION; MOUSE EMBRYO; NECROPTOSIS; NONHUMAN; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SURVIVAL FACTOR; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; AUTOPHAGY; CELL DEATH; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; CASPASE 8; CELL DEATH; CELL SURVIVAL; HUMANS; SIGNAL TRANSDUCTION;

EID: 84904047854     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.03.005     Document Type: Review

References (123)

1. Horvitz H.R. Nobel lecture. Worms, life and death. Biosci Rep 2003, 23(5-6):239-303.
2. Alnemri E., Livingston D., Nicholson D., Salvesen G., Thornberry N., Wong W. Human ICE/CED-3 protease nomenclature [Letter]. Cell 1996, 87:171.
3. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999, 13(15):1899-1911.
4. Thornberry N., Rano T., Peterson E., Rasper D., Timkey T., Garcia-Calvo M. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997, 272(29):17907-17911.
5. Stennicke H.R., Salvesen G.S. Biochemical characteristics of caspases-3, -6, -7, and -8. J Biol Chem 1997, 272(41):25719-25723.
6. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997, 272(29):17907-17911.
7. Talanian R.V., Quinlan C., Trautz S., Hackett M.C., Mankovich J.A., Banach D. Substrate specificities of caspase family proteases. J Biol Chem 1997, 272(15):9677-9682.
8. Stennicke H.R., Renatus M., Meldal M., Salvesen G.S. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem J 2000, 350(Pt 2):563-568.
9. Vandenabeele P., Declercq W., Beyaert R., Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 1995, 5(10):392-399.
10. Muzio M., Chinnaiyan A., Kischkel F., O'Rourke K., Shevchenko A., Ni J. FLICE: a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996, 85(6):817-827.
11. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH: a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996, 85(6):803-815.
12. Anilkumar T.V., Sarraf C.E., Alison M.R. The biology and pathology of programmed cell death (apoptosis). Vet Hum Toxicol 1992, 34(3):251-254.
13. Stennicke H.R., Salvesen G.S. Caspases - controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta 2000, 1477(1-2):299-306.
14. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J.S., Mett I.L. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors: Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998, 9(2):267-276.
15. Chun H.J., Zheng L., Ahmad M., Wang J., Speirs C.K., Siegel R.M. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002, 419(6905):395-399.
16. Vercammen D., Beyaert R., Denecker G., Goossens V., Van Loo G., Declercq W. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998, 187(9):1477-1485.
17. Degterev A., Hitomi J., Germscheid M., Ch'en I.L., Korkina O., Teng X. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008, 4(5):313-321.
18. Green D.R., Oberst A., Dillon C.P., Weinlich R., Salvesen G.S. RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol Cell 2011, 44(1):9-16.
19. Wallach D., Kovalenko A., Kang T.B. 'Necrosome'-induced inflammation: must cells die for it?. Trends Immunol 2011, 32(11):505-509.
20. Feoktistova M., Geserick P., Kellert B., Dimitrova D.P., Langlais C., Hupe M. cIAPs block ripoptosome formation: a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011, 43(3):449-463.
21. Tenev T., Bianchi K., Darding M., Broemer M., Langlais C., Wallberg F. The ripoptosome: a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011, 43(3):432-448.
22. Pop C., Salvesen G.S. Human caspases: activation, specificity, and regulation. J Biol Chem 2009, 284(33):21777-21781.
23. MacKenzie S.H., Clark A.C. Death by caspase dimerization. Adv Exp Med Biol 2012, 747:55-73.
24. Lemmon M.A., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010, 141(7):1117-1134.
25. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., Dixit V.M. An induced proximity model for caspase-8 activation. J Biol Chem 1998, 273(5):2926-2930.
26. Boatright K.M., Renatus M., Scott F.L., Sperandio S., Shin H., Pedersen I.M. A unified model for apical caspase activation. Mol Cell 2003, 11(2):529-541.
27. Riedl S.J., Salvesen G.S. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007, 8(5):405-413.
28. Donepudi M., Mac Sweeney A., Briand C., Grütter M.G. Insights into the regulatory mechanism for caspase-8 activation. Mol Cell 2003, 11:543-549.
29. Renatus M., Stennicke H.R., Scott F.L., Liddington R.C., Salvesen G.S. Dimer formation drives the activation of the cell death protease caspase 9. Proc Natl Acad Sci U S A 2001, 98:14250-14255.
30. Hughes M.A., Harper N., Butterworth M., Cain K., Cohen G.M., MacFarlane M. Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol Cell 2009, 35(3):265-279.
31. Pop C., Fitzgerald P., Green D.R., Salvesen G.S. Role of proteolysis in caspase-8 activation and stabilization. Biochemistry 2007, 46(14):4398-4407.
32. Pop C., Timmer J., Sperandio S., Salvesen G.S. The apoptosome activates caspase-9 by dimerization. Mol Cell 2006, 22(2):269-275.
33. Graf R.P., Keller N., Barbero S., Stupack D. Caspase-8 as a regulator of tumor cell motility. Curr Mol Med 2014, 14(2):246-254.
34. Jin Z., Li Y., Pitti R., Lawrence D., Pham V.C., Lill J.R. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 2009, 137(4):721-735.
35. Gonzalvez F., Lawrence D., Yang B., Yee S., Pitti R., Marsters S. TRAF2 sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol Cell 2012, 48(6):888-899.
36. Zhang H.G., Wang J., Yang X., Hsu H.C., Mountz J.D. Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 2004, 23(11):2009-2015.
37. Kurokawa M., Kornbluth S. Caspases and kinases in a death grip. Cell 2009, 138(5):838-854.
38. van Raam B.J., Salvesen G.S. Proliferative versus apoptotic functions of caspase-8 hetero or homo: the caspase-8 dimer controls cell fate. Biochim Biophys Acta 2012, 1824(1):113-122.
39. Toivonen H.T., Meinander A., Asaoka T., Westerlund M., Pettersson F., Mikhailov A. Modeling reveals that dynamic regulation of c-FLIP levels determines cell-to-cell distribution of CD95-mediated apoptosis. J Biol Chem 2011, 286(21):18375-18382.
40. L and initiates cell death. Proc Natl Acad Sci U S A 1997, 94:11333-11338.
41. Hu S., Vincenz C., Ni J., Gentz R., Dixit V.M. I-FLICE: a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem 1997, 272(28):17255-17257.
42. Rasper D.M., Vaillancourt J.P., Hadano S., Houtzager V.M., Seiden I., Keen S.L. Cell death attenuation by 'Usurpin': a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ 1998, 5(4):271-288.
43. Shu H.B., Halpin D.R., Goeddel D.V. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 1997, 6(6):751-763.
44. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V. Inhibition of death receptors signals by cellular FLIP. Nature 1997, 388:190-195.
45. Scaffidi C., Schmitz I., Krammer P.H., Peter M.E. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999, 274(3):1541-1548.
46. Boatright K.M., Deis C., Denault J.B., Sutherlin D.P., Salvesen G.S. Activation of caspases-8 and -10 by FLIP(L). Biochem J 2004, 382(Pt 2):651-657.
47. Dohrman A., Kataoka T., Cuenin S., Russell J.Q., Tschopp J., Budd R.C. Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-kappa B activation. J Immunol 2005, 174(9):5270-5278.
48. Micheau O., Thome M., Schneider P., Holler N., Tschopp J., Nicholson D.W. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 2002, 277(47):45162-45171.
49. Yu J.W., Jeffrey P.D., Shi Y. Mechanism of procaspase-8 activation by c-FLIPL. Proc Natl Acad Sci U S A 2009, 106(20):8169-8174.
50. Pop C., Oberst A., Drag M., Van Raam B.J., Riedl S.J., Green D.R. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem J 2011, 433(3):447-457.
51. Sakamaki K., Satou Y. Caspases: evolutionary aspects of their functions in vertebrates. J Fish Biol 2009, 74(4):727-753.
52. Eckhart L., Ballaun C., Hermann M., VandeBerg J.L., Sipos W., Uthman A. Identification of novel mammalian caspases reveals an important role of gene loss in shaping the human caspase repertoire. Mol Biol Evol 2008, 25(5):831-841.
53. Ashkenazi A., Dixit V. Death receptors: signaling and modulation. Science 1998, 281(5381):1305-1308.
54. Walsh C.M., Luhrs K.A., Arechiga A.F. The fuzzy logic of the death-inducing signaling complex in lymphocytes. J Clin Immunol 2003, 23(5):333-353.
55. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992, 356(6367):314-317.
56. Roths J.B., Murphy E.D., Eicher E.M. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J Exp Med 1984, 159(1):1-20.
57. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 1993, 75(6):1169-1178.
58. Takahashi T., Tanaka M., Brannan C., Jenkins N., Copeland N., Suda T. Generalized lymphoproliferative disease in mice: caused by a point mutation in the Fas ligand. Cell 1994, 76(6):969-976.
59. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD: a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81(4):505-512.
60. Kischkel F., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P. Cytotoxicity-dependent APO-1 Fas/CD95-associated proteins form a death-inducing signaling complex DISC with the receptor. EMBO J 1995, 14:5579-5588.
61. Chinnaiyan A., Tepper C., Seldin M., O'Rourke K., Kischkel F., Hellbardt S. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996, 271(9):4961-4965.
62. Newton K., Harris A.W., Bath M.L., Smith K.G., Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J 1998, 17(3):706-718.
63. Walsh C.M., Wen B.G., Chinnaiyan A.M., O'Rourke K., Dixit V.M., Hedrick S.M. A role for FADD in T cell activation and development. Immunity 1998, 8(4):439-449.
64. Zhang J., Cado D., Chen A., Kabra N.H., Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998, 392(6673):296-300.
65. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Litwack G., Alnemri E.S. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci U S A 1996, 93(25):14486-14491.
66. Salmena L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Au P.Y. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003, 17(7):883-895.
67. Yeh W.C., Pompa J.L., McCurrach M.E., Shu H.B., Elia A.J., Shahinian A. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998, 279(5358):1954-1958.
68. Yeh W.C., Itie A., Elia A.J., Ng M., Shu H.B., Wakeham A. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000, 12(6):633-642.
69. Zhang N., He Y.W. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J Exp Med 2005, 202(3):395-404.
70. Chau H., Wong V., Chen N.J., Huang H.L., Lin W.J., Mirtsos C. Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J Exp Med 2005, 202(3):405-413.
71. Zhang Y., Rosenberg S., Wang H., Imtiyaz H.Z., Hou Y.J., Zhang J. Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis. J Immunol 2005, 175(5):3033-3044.
72. Beisner D.R., Chu I.H., Arechiga A.F., Hedrick S.M., Walsh C.M. The requirements for Fas-associated death domain signaling in mature T cell activation and survival. J Immunol 2003, 171(1):247-256.
73. Imtiyaz H.Z., Rosenberg S., Zhang Y., Rahman Z.S., Hou Y.J., Manser T. The Fas-associated death domain protein is required in apoptosis and TLR-induced proliferative responses in B cells. J Immunol 2006, 176(11):6852-6861.
74. Arechiga A.F., Bell B.D., Solomon J.C., Chu I.H., Dubois C.L., Hall B.E. Cutting edge: FADD is not required for antigen receptor-mediated NF-{kappa}B activation. J Immunol 2005, 175(12):7800-7804.
75. Beisner D.R., Ch'en I.L., Kolla R.V., Hoffmann A., Hedrick S.M. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J Immunol 2005, 175(6):3469-3473.
76. Zhang N., Hopkins K., He Y.W. c-FLIP protects mature T lymphocytes from TCR-mediated killing. J Immunol 2008, 181(8):5368-5373.
77. Zhang N., Hopkins K., He Y.W. The long isoform of cellular FLIP is essential for T lymphocyte proliferation through an NF-kappaB-independent pathway. J Immunol 2008, 180(8):5506-5511.
78. Zhang H., Rosenberg S., Coffey F.J., He Y.W., Manser T., Hardy R.R. A role for cFLIP in B cell proliferation and stress MAPK regulation. J Immunol 2009, 182(1):207-215.
79. Coffey F., Manser T. Expression of cellular FLIP by B cells is required for their participation in an immune response. J Immunol 2010, 184(9):4871-4879.
80. Lu J.V., Walsh C.M. Programmed necrosis and autophagy in immune function. Immunol Rev 2012, 249(1):205-217.
81. Kennedy N.J., Kataoka T., Tschopp J., Budd R.C. Caspase activation is required for T cell proliferation. J Exp Med 1999, 190(12):1891-1896.
82. Alam A., Cohen L.Y., Aouad S., Sékaly R.-P. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 1999, 190(12):1879-1890.
83. Leverrier S., Salvesen G.S., Walsh C.M. Enzymatically active single chain caspase-8 maintains T-cell survival during clonal expansion. Cell Death Differ 2011, 18(1):90-98.
84. Salvesen G.S., Dixit V.M. Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 1999, 96(20):10964-10967.
85. Kang T.B., Oh G.S., Scandella E., Bolinger B., Ludewig B., Kovalenko A. Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice. J Immunol 2008, 181(4):2522-2532.
86. O'Reilly L.A., Divisekera U., Newton K., Scalzo K., Kataoka T., Puthalakath H. Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes. Cell Death Differ 2004, 11(7):724-736.
87. Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290(5497):1717-1721.
88. Pua H.H., He Y.W. Autophagy and lymphocyte homeostasis. Curr Top Microbiol Immunol 2009, 335:85-105.
89. Lum J.J., DeBerardinis R.J., Thompson C.B. Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol 2005, 6(6):439-448.
90. Edinger A.L., Thompson C.B. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004, 16(6):663-669.
91. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012, 19(1):107-120.
92. Yu L., Lenardo M.J., Baehrecke E.H. Autophagy and caspases: a new cell death program. Cell Cycle 2004, 3(9):1124-1126.
93. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122(6):927-939.
94. Yu L., Alva A., Su H., Dutt P., Freundt E., Welsh S. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304(5676):1500-1502.
95. Pyo J.O., Jang M.H., Kwon Y.K., Lee H.J., Jun J.I., Woo H.N. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem 2005, 280(21):20722-20729.
96. Lee J.S., Li Q., Lee J.Y., Lee S.H., Jeong J.H., Lee H.R. FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol 2009, 11(11):1355-1362.
97. Walsh C.M., Edinger A.L. The complex interplay between autophagy, apoptosis, and necrotic signals promotes T-cell homeostasis. Immunol Rev 2010, 236:95-109.
98. Bell B.D., Leverrier S., Weist B.M., Newton R.H., Arechiga A.F., Luhrs K.A. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A 2008, 105(43):16677-16682.
99. Ch'en I.L., Beisner D.R., Degterev A., Lynch C., Yuan J., Hoffmann A. Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci U S A 2008, 105(45):17463-17468.
100. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S. Fas triggers an alternative: caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000, 1(6):489-495.
101. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005, 1(2):112-119.
102. Kawahara A., Ohsawa Y., Matsumura H., Uchiyama Y., Nagata S. Caspase-independent cell killing by Fas-associated protein with death domain. J Cell Biol 1998, 143(5):1353-1360.
103. Hitomi J., Christofferson D.E., Ng A., Yao J., Degterev A., Xavier R.J. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135(7):1311-1323.
104. Degterev A., Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 2008, 9(5):378-390.
105. Osborn S.L., Diehl G., Han S.J., Xue L., Kurd N., Hsieh K. Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc Natl Acad Sci U S A 2010, 107(29):13034-13039.
106. Feng S., Yang Y., Mei Y., Ma L., Zhu D.E., Hoti N. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 2007, 19(10):2056-2067.
107. Zhang D.W., Shao J., Lin J., Zhang N., Lu B.J., Lin S.C. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009, 325(5938):332-336.
108. He S.W.L., Miao L., Wang T., Du F., Zhao L., Wang X. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137(6):1100-1111.
109. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137(6):1112-1123.
110. Declercq W., Vanden Berghe T., Vandenabeele P. RIP kinases at the crossroads of cell death and survival. Cell 2009, 138(2):229-232.
111. Vandenabeele P., Declercq W., Van Herreweghe F., Vanden Berghe T. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal 2010, 3(115):re4.
112. Kaiser W.J., Upton J.W., Long A.B., Livingston-Rosanoff D., Daley-Bauer L.P., Hakem R. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011, 471(7338):368-372.
113. Zhang H., Zhou X., McQuade T., Li J., Chan F.K., Zhang J. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011, 471(7338):373-376.
114. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471(7338):363-367.
115. Lu J.V., Weist B.M., van Raam B.J., Marro B.S., Nguyen L.V., Srinivas P. Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A 2011, 108(37):15312-15317.
116. Ch'en I.L., Tsau J.S., Molkentin J.D., Komatsu M., Hedrick S.M. Mechanisms of necroptosis in T cells. J Exp Med 2011, 208(4):633-641.
117. Lin Y., Devin A., Rodriguez Y., Liu Z.-G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 1999, 13(19):2514-2526.
118. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998, 8(3):297-303.
119. Ting A.T., Pimentel-Muinos F.X., Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J 1996, 15(22):6189-6196.
120. van Raam B.J., Ehrnhoefer D.E., Hayden M.R., Salvesen G.S. Intrinsic cleavage of receptor-interacting protein kinase-1 by caspase-6. Cell Death Differ 2013, 20(1):86-96.
121. O'Donnell M.A., Perez-Jimenez E., Oberst A., Ng A., Massoumi R., Xavier R. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 2011, 13(12):1437-1442.
122. Dillon C.P., Oberst A., Weinlich R., Janke L.J., Kang T.B., Ben-Moshe T. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 2012, 1(5):401-407.
123. Bell B.D., Walsh C.M. Coordinate regulation of autophagy and apoptosis in T cells by death effectors: FADD or foundation. Autophagy 2009, 5(2):238-240.